focus -WSS

focus

author：fashion 2025-09-29 16:45:57 - browse：1661

From left: Daphne Koller, CEO of Insitro, Vijay Pande of Andreessen Horowitz and scientist Derek Lowe speaking at STAT's Breakthrough Summit in San Francisco. Sarah Gonzalez for STAT

Artificial intelligence is a rapidly improving technology. But its progress in drug development faces an increasingly urgent threat: An unending stream of overheated marketing.

To read of AI’s feats in press releases is to learn of a miracle product on the verge of unraveling biology’s most enduring secrets. It can map molecules and accurately predict how they fit together on computer screens. All you need to get to a cure — as they say in infomercials — is act now!

“I am very worried about the hype,” said Daphne Koller, chief executive of the machine learning drug discovery company Insitro, said during STAT’s Breakthrough West Summit in San Francisco last week. “People think (the breakthrough) is going to happen tomorrow.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： New weight loss drugs work. But how can they best be used?

WSS

Why some fertility treatments produce more boy babies

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

The Bio Revolution is changing business and society

UCB departs biotech trade group BIO

J&J reports mixed data on next

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

hotspot

focus

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

focus

Medical leaders decry Supreme Court decision on affirmative action

Feng Zhang CRISPR delivery startup lays off quarter of staff

Medical leaders decry Supreme Court decision on affirmative action

AdventHealth escalates lawsuit against insurance vendor Multiplan

Dobbs anniversary: the lost opportunity of abortion as health care

Why some fertility treatments produce more boy babies

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Duchenne breakthrough therapy leaves behind pioneering families

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

leisure time

Lawsuit challenges CMS nursing home minimum staffing rule

U.S. death rates show how politics are affecting public health

Stroke rates rising, especially in working

The biotech scorecard for Q1: 17 stock

AdventHealth escalates lawsuit against insurance vendor Multiplan

JPM: CVS says Medicare Advantage patients are impacting profits

leisure time

leisure time

entertainment

knowledge